tirzepatide, trial data suggest that such differences may relate to differences in background (placebo) rates in the enrolled trial populations, with the relative increase in many side effects being similar for the two agents (Table 2)
Our retention went up noticeably
Measuring biomarkers like fasting insulin, C-peptide, and inflammatory markers (hsCRP) can provide context for whether your metabolic profile aligns with conditions where prescription GLP-1 therapy has the strongest clinical evidence
If symptoms persist or worsen, its important to contact your healthcare provider for guidance and possible adjustments to your treatment plan
If your gut lining becomes leaky, toxins from bacteria can enter your bloodstream, triggering inflammation that makes it even harder for insulin and GLP-1 to do their jobs
#Lipedema #LipedemaResearch #GLP1 #Exenatide #Tirzepatide #Ozempic #LegsLikeMine #LipedemaHope #PatientAdvocacy #ChronicPain #WomenInMedicine #LegsLikeMiine #lipedemaawareness Lipedema World Alliance American Lipedema Association Lipedema Foundation | Legs Like Mine